Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease: results of a multicenter survey
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - May 10, 2023 Category: Drugs & Pharmacology Authors: Patr ícia Sarlós Alexander Bikar Nelli Farkas Tam ás Resál Zolt án Szepes Klaudia Farkas Ferenc Nagy Áron Vincze Pal Miheller Tam ás Molnár Source Type: research

Potential applications of mesenchymal stem cells and their derived exosomes in regenerative medicine
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - May 9, 2023 Category: Drugs & Pharmacology Authors: Maryam Adelipour David M. Lubman Jeongkwon Kim Source Type: research

Interferon lambda as a potential treatment for COVID-19
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - May 8, 2023 Category: Drugs & Pharmacology Authors: Matthew W McCarthy Source Type: research

Dental stem cells for tooth regeneration: how far have we come and where next?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - May 2, 2023 Category: Drugs & Pharmacology Authors: Christian Morsczeck Source Type: research

REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicenter, single-arm, Phase IV itolizumab Trial: RESURRECT
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 28, 2023 Category: Drugs & Pharmacology Authors: Raveendra KR Chirag Rathod Rahul Darnule Subramanian Loganathan Sarika Deodhar Radhika A Ashwani Marwah Nitin M Chaudhari Binay K Thakur Sivakumar Vaidyanathan Sandeep Nilkanth Athalye Source Type: research

Advances in the development of tumor-infiltrating lymphocyte therapy for advanced melanoma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 27, 2023 Category: Drugs & Pharmacology Authors: Max Julve Andrew JS Furness Source Type: research

Advances in biological and targeted therapies for systemic sclerosis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 26, 2023 Category: Drugs & Pharmacology Authors: Erica Mulcaire-Jones Andrea Hsiu Ling Low Robyn Domsic Michael L Whitfield Dinesh Khanna Source Type: research

Genetic modification and preconditioning strategies to enhance functionality of mesenchymal stromal cells: a clinical perspective
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 24, 2023 Category: Drugs & Pharmacology Authors: Kasra Moeinabadi-Bidgoli Radman Mazloomnejad Alireza Beheshti Maal Hamid Asadzadeh Aghdaei Mandana Kazem Arki Nikoo Hossein-Khannazer Massoud Vosough Source Type: research

Recent advances in stem cell therapy for erectile dysfunction: a narrative review
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 20, 2023 Category: Drugs & Pharmacology Authors: Bohan Wang Wenjun Gao Micha Y. Zheng Guiting Lin Tom F Lue Source Type: research

Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia
Volume 23, Issue 8, July - December 2023 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 19, 2023 Category: Drugs & Pharmacology Authors: Emilia AndersonKaren WallerAravind Gokul TamilarasanHuiyu LinSudarshan ParamsothyRupert W Leonga Department of Gastroenterology and Hepatology, Concord Repatriation General Hospital, Sydney, NSW, Australiab Faculty of Medicine and Health, Concord Clinical Source Type: research

Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 19, 2023 Category: Drugs & Pharmacology Authors: Emilia Anderson Karen Waller Aravind Gokul Tamilarasan Huiyu Lin Sudarshan Paramsothy Rupert W Leong Source Type: research

Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)
Volume 23, Issue 8, July - December 2023 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 17, 2023 Category: Drugs & Pharmacology Authors: Bernd BokemeyerTibor HlavatyMatthieu AllezPamela SelemaShahrzad MoosaviMary Jane CadatalHeather FowlerMarkus MuellerKatherine F LiauJavier P Gisberta Interdisciplinary Crohn Colitis Centre Minden, Minden, Germanyb 5th Department of Internal Medicine, Sub- Source Type: research

Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 17, 2023 Category: Drugs & Pharmacology Authors: Bernd Bokemeyer Tibor Hlavaty Matthieu Allez Pamela Selema Shahrzad Moosavi Mary Jane Cadatal Heather Fowler Markus Mueller Katherine F Liau Javier P Gisbert Source Type: research

Stem cell therapy for salivary gland regeneration after radiation injury
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 11, 2023 Category: Drugs & Pharmacology Authors: Akshaya Upadhyay Simon D Tran Source Type: research

Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 10, 2023 Category: Drugs & Pharmacology Authors: Andreia Bil é-Silva Antonio Lopez-Beltran Ana Blanca Fernando Lopez-Rios Enrique G ómez-Gómez Alessia Cimadamore Rodolfo Montironi Nuno Vau Liang Cheng Source Type: research